Global Anti-PD-1 MAb Industry Growth and Trends Forecast to 2031
Description
Summary
According to APO Research, The global Anti-PD-1 MAb market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Anti-PD-1 MAb is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Anti-PD-1 MAb is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Anti-PD-1 MAb is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global companies of Anti-PD-1 MAb include Thermo Fisher Scientific, Merck KGaA, Ximbio, Sino Biological, OriGene Technologies, Leinco Technologies, Elabscience and BioVision, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-PD-1 MAb, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-PD-1 MAb.
The Anti-PD-1 MAb market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-PD-1 MAb market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Anti-PD-1 MAb Segment by Company
Thermo Fisher Scientific
Merck KGaA
Ximbio
Sino Biological
OriGene Technologies
Leinco Technologies
Elabscience
BioVision
Anti-PD-1 MAb Segment by Type
1mg
2.5mg
Others
Anti-PD-1 MAb Segment by Application
Pharmaceutical
Research
Other
Anti-PD-1 MAb Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-PD-1 MAb market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-PD-1 MAb and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-PD-1 MAb.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Anti-PD-1 MAb companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
According to APO Research, The global Anti-PD-1 MAb market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Anti-PD-1 MAb is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Anti-PD-1 MAb is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Anti-PD-1 MAb is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global companies of Anti-PD-1 MAb include Thermo Fisher Scientific, Merck KGaA, Ximbio, Sino Biological, OriGene Technologies, Leinco Technologies, Elabscience and BioVision, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-PD-1 MAb, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-PD-1 MAb.
The Anti-PD-1 MAb market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-PD-1 MAb market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Anti-PD-1 MAb Segment by Company
Thermo Fisher Scientific
Merck KGaA
Ximbio
Sino Biological
OriGene Technologies
Leinco Technologies
Elabscience
BioVision
Anti-PD-1 MAb Segment by Type
1mg
2.5mg
Others
Anti-PD-1 MAb Segment by Application
Pharmaceutical
Research
Other
Anti-PD-1 MAb Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-PD-1 MAb market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-PD-1 MAb and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-PD-1 MAb.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Anti-PD-1 MAb companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Table of Contents
88 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Anti-PD-1 MAb Market Size Overview by Region 2020 VS 2024 VS 2031
- 1.4 Global Anti-PD-1 MAb Market Size by Region (2020-2031)
- 1.4.1 Global Anti-PD-1 MAb Market Size by Region (2020-2025)
- 1.4.2 Global Anti-PD-1 MAb Market Size by Region (2026-2031)
- 1.5 Key Regions Anti-PD-1 MAb Market Size (2020-2031)
- 1.5.1 North America Anti-PD-1 MAb Market Size Growth Rate (2020-2031)
- 1.5.2 Europe Anti-PD-1 MAb Market Size Growth Rate (2020-2031)
- 1.5.3 Asia-Pacific Anti-PD-1 MAb Market Size Growth Rate (2020-2031)
- 1.5.4 South America Anti-PD-1 MAb Market Size Growth Rate (2020-2031)
- 1.5.5 Middle East & Africa Anti-PD-1 MAb Market Size Growth Rate (2020-2031)
- 2 Anti-PD-1 MAb Market by Type
- 2.1 Type Introduction
- 2.1.1 1mg
- 2.1.2 2.5mg
- 2.1.3 Others
- 2.2 Global Anti-PD-1 MAb Market Size by Type
- 2.2.1 Global Anti-PD-1 MAb Market Size Overview by Type (2020-2031)
- 2.2.2 Global Anti-PD-1 MAb Historic Market Size Review by Type (2020-2025)
- 2.2.3 Global Anti-PD-1 MAb Market Size Forecasted by Type (2026-2031)
- 2.3 Global Anti-PD-1 MAb Market Size by Regions
- 2.3.1 North America Anti-PD-1 MAb Market Size Breakdown by Type (2020-2025)
- 2.3.2 Europe Anti-PD-1 MAb Market Size Breakdown by Type (2020-2025)
- 2.3.3 Asia-Pacific Anti-PD-1 MAb Market Size Breakdown by Type (2020-2025)
- 2.3.4 South America Anti-PD-1 MAb Market Size Breakdown by Type (2020-2025)
- 2.3.5 Middle East and Africa Anti-PD-1 MAb Market Size Breakdown by Type (2020-2025)
- 3 Anti-PD-1 MAb Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical
- 3.1.2 Research
- 3.1.3 Other
- 3.2 Global Anti-PD-1 MAb Market Size by Application
- 3.2.1 Global Anti-PD-1 MAb Market Size Overview by Application (2020-2031)
- 3.2.2 Global Anti-PD-1 MAb Historic Market Size Review by Application (2020-2025)
- 3.2.3 Global Anti-PD-1 MAb Market Size Forecasted by Application (2026-2031)
- 3.3 Global Anti-PD-1 MAb Market Size by Regions
- 3.3.1 North America Anti-PD-1 MAb Market Size Breakdown by Application (2020-2025)
- 3.3.2 Europe Anti-PD-1 MAb Market Size Breakdown by Application (2020-2025)
- 3.3.3 Asia-Pacific Anti-PD-1 MAb Market Size Breakdown by Application (2020-2025)
- 3.3.4 South America Anti-PD-1 MAb Market Size Breakdown by Application (2020-2025)
- 3.3.5 Middle East and Africa Anti-PD-1 MAb Market Size Breakdown by Application (2020-2025)
- 4 Global Market Dynamics
- 4.1 Anti-PD-1 MAb Industry Trends
- 4.2 Anti-PD-1 MAb Industry Drivers
- 4.3 Anti-PD-1 MAb Industry Opportunities and Challenges
- 4.4 Anti-PD-1 MAb Industry Restraints
- 5 Competitive Insights by Company
- 5.1 Global Top Players by Anti-PD-1 MAb Revenue (2020-2025)
- 5.2 Global Anti-PD-1 MAb Industry Company Ranking, 2023 VS 2024 VS 2025
- 5.3 Global Anti-PD-1 MAb Key Company Headquarters & Area Served
- 5.4 Global Anti-PD-1 MAb Company, Product Type & Application
- 5.5 Global Anti-PD-1 MAb Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Anti-PD-1 MAb Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Anti-PD-1 MAb Players Market Share by Revenue in 2024
- 5.6.3 2024 Anti-PD-1 MAb Tier 1, Tier 2, and Tier 3
- 6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Comapny Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2020-2025)
- 6.1.4 Thermo Fisher Scientific Anti-PD-1 MAb Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Merck KGaA
- 6.2.1 Merck KGaA Comapny Information
- 6.2.2 Merck KGaA Business Overview
- 6.2.3 Merck KGaA Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2020-2025)
- 6.2.4 Merck KGaA Anti-PD-1 MAb Product Portfolio
- 6.2.5 Merck KGaA Recent Developments
- 6.3 Ximbio
- 6.3.1 Ximbio Comapny Information
- 6.3.2 Ximbio Business Overview
- 6.3.3 Ximbio Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2020-2025)
- 6.3.4 Ximbio Anti-PD-1 MAb Product Portfolio
- 6.3.5 Ximbio Recent Developments
- 6.4 Sino Biological
- 6.4.1 Sino Biological Comapny Information
- 6.4.2 Sino Biological Business Overview
- 6.4.3 Sino Biological Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2020-2025)
- 6.4.4 Sino Biological Anti-PD-1 MAb Product Portfolio
- 6.4.5 Sino Biological Recent Developments
- 6.5 OriGene Technologies
- 6.5.1 OriGene Technologies Comapny Information
- 6.5.2 OriGene Technologies Business Overview
- 6.5.3 OriGene Technologies Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2020-2025)
- 6.5.4 OriGene Technologies Anti-PD-1 MAb Product Portfolio
- 6.5.5 OriGene Technologies Recent Developments
- 6.6 Leinco Technologies
- 6.6.1 Leinco Technologies Comapny Information
- 6.6.2 Leinco Technologies Business Overview
- 6.6.3 Leinco Technologies Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2020-2025)
- 6.6.4 Leinco Technologies Anti-PD-1 MAb Product Portfolio
- 6.6.5 Leinco Technologies Recent Developments
- 6.7 Elabscience
- 6.7.1 Elabscience Comapny Information
- 6.7.2 Elabscience Business Overview
- 6.7.3 Elabscience Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2020-2025)
- 6.7.4 Elabscience Anti-PD-1 MAb Product Portfolio
- 6.7.5 Elabscience Recent Developments
- 6.8 BioVision
- 6.8.1 BioVision Comapny Information
- 6.8.2 BioVision Business Overview
- 6.8.3 BioVision Anti-PD-1 MAb Revenue, Global Share and Gross Margin (2020-2025)
- 6.8.4 BioVision Anti-PD-1 MAb Product Portfolio
- 6.8.5 BioVision Recent Developments
- 7 North America
- 7.1 North America Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2 North America Anti-PD-1 MAb Market Size by Country (2020-2025)
- 7.3 North America Anti-PD-1 MAb Market Size Forecast by Country (2026-2031)
- 8 Europe
- 8.1 Europe Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2 Europe Anti-PD-1 MAb Market Size by Country (2020-2025)
- 8.3 Europe Anti-PD-1 MAb Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2 Asia-Pacific Anti-PD-1 MAb Market Size by Country (2020-2025)
- 9.3 Asia-Pacific Anti-PD-1 MAb Market Size Forecast by Country (2026-2031)
- 10 South America
- 10.1 South America Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2 South America Anti-PD-1 MAb Market Size by Country (2020-2025)
- 10.3 South America Anti-PD-1 MAb Market Size Forecast by Country (2026-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2 Middle East & Africa Anti-PD-1 MAb Market Size by Country (2020-2025)
- 11.3 Middle East & Africa Anti-PD-1 MAb Market Size Forecast by Country (2026-2031)
- 12 Concluding Insights
- 13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
